Bristol-Myers Squibb Company
Utility Patents
Last updated:
List of all Bristol-Myers Squibb Company patents 334 in total
| Status | Patent |
|---|---|
Grant | Utility: Methods for treating patients at risk for costimulation blockade resistant rejection with belatacept Filling date: 6 Sep 2025 Issue date: 26 Nov 2019 |
Grant | Utility: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Filling date: 6 Sep 2025 Issue date: 19 Nov 2019 |
Grant | Utility: Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Filling date: 6 Sep 2025 Issue date: 19 Nov 2019 |
Grant | Utility: Antibodies to CD40 with enhanced agonist activity Filling date: 6 Sep 2025 Issue date: 19 Nov 2019 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 12 Nov 2019 |
Grant | Utility: Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Filling date: 6 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Fibronectin binding domains with reduced immunogenicity Filling date: 6 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 29 Oct 2019 |
Grant | Utility: Method of using human FC-bearing IGG antibodies to polyethylene glycol Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: CXCR4 receptor antagonists Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Stabilized fibronectin based scaffold molecules Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Serum albumin-binding fibronectin type III domains Filling date: 6 Sep 2025 Issue date: 15 Oct 2019 |
Grant | Utility: Substituted tetrahydrocarbazole and carbazole carboxamide compounds Filling date: 6 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Tricyclic sulfones as ROR gamma modulators Filling date: 6 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Method of using antibody polypeptides that antagonize CD40 to treat IBD Filling date: 6 Sep 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation Filling date: 6 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Treatment of hematologic malignancies with an anti-CXCR4 antibody Filling date: 6 Sep 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Fibronectin based scaffold domain proteins that bind to myostatin Filling date: 6 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Triazolopyridine inhibitors of myeloperoxidase Filling date: 6 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Polypeptides targeting HIV fusion Filling date: 6 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: PD-L1 binding polypeptides for imaging Filling date: 6 Sep 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Antiproliferative compounds and conjugates made therefrom Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: B7-related nucleic acids and polypeptides useful for immunomodulation Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: TGF beta receptor antagonists Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Injection aid for use with an injection device and method of use Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Grant | Utility: 2,4-dihydroxy-nicotinamides as APJ agonists Filling date: 6 Sep 2025 Issue date: 27 Aug 2019 |
Grant | Utility: Phthalazinones and isoquinolinones as rock inhibitors Filling date: 6 Sep 2025 Issue date: 20 Aug 2019 |
Grant | Utility: Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Filling date: 6 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereof Filling date: 6 Sep 2025 Issue date: 13 Aug 2019 |
Grant | Utility: Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Filling date: 6 Sep 2025 Issue date: 6 Aug 2019 |
Grant | Utility: Methods of treatment using CTLA4 mutant molecules Filling date: 6 Sep 2025 Issue date: 6 Aug 2019 |
Showing 300 to 334 of 334 patents.